25-hydroxy-vitamin-D in nephrotic syndrome.

Area of Science:

• Nephrology
• Endocrinology
• Nutritional Science

Background:

• Nephrotic syndrome (N.S.) is characterized by significant proteinuria.
• Vitamin D deficiency is a potential complication, but its mechanism in N.S. is not fully understood.
• Serum 25-hydroxy-vitamin D (25-OHD) is the primary indicator of vitamin D status.

Purpose of the Study:

• To investigate serum and urinary vitamin D metabolites and binding proteins in nephrotic syndrome patients without renal insufficiency.
• To determine the relationship between vitamin D status and protein losses in N.S.
• To explore potential mechanisms for vitamin D deficiency in N.S.

Main Methods:

• Measured serum 25-OHD levels in N.S. patients and controls.
• Quantified serum Gc-globulin (vitamin D-binding protein, D.B.P.) concentrations using radial immunodiffusion.
• Analyzed urine for 25-OHD-binding capacity and D.B.P. using concentration and Scatchard analysis.

Main Results:

• Serum 25-OHD levels were significantly lower in N.S. patients (mean 19 nmol/L) compared to normal ranges (25-200 nmol/L).
• Serum Gc-globulin levels were significantly lower in N.S. patients (mean 340 mg/L) versus controls (mean 440 mg/L).
• Urine from N.S. patients showed high 25-OHD-binding capacity, with detectable D.B.P., suggesting urinary protein-bound vitamin D loss.

Conclusions:

• Acquired deficiency of circulating 25-OHD in N.S. is likely secondary to urinary losses of protein-bound 25-OHD.
• Urinary loss of Gc-globulin contributes to vitamin D deficiency in N.S.
• The clinical significance of low 25-OHD levels in N.S. requires further investigation, though borderline vitamin D depletion is suggested by elevated PTH.